BeautyHealth to Participate in TD Cowen’s 7th Annual Future of the Consumer Conference
23 May 2023
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that President and Chief Executive Officer Andrew Stanleick and Chief Financial Officer Liyuan Woo will participate in a fireside chat at TD Cowen’s 7th Annual Future of the Consumer Conference on Tuesday, June 6, 2023 at 8:00 a.m. ET in New York, NY.
The audio portion of the fireside chat will be webcast live on the Company’s investor relations website at https://investors.beautyhealth.com/. An archived replay of the webcast will be available following the fireside chat.
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types in more than 90 countries. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/, and learn more at beautyhealth.com or LinkedIn.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.